Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Adv Drug Deliv Rev. 2016 May 2;103:187–201. doi: 10.1016/j.addr.2016.04.027

Figure 1.

Figure 1

Genetic modification of CD34+ HSPC to resist HIV infection. Anti-HIV gene modified CD34+ hematopoietic stem/progenitor cells (HSPC) can self renew and proliferate to continuously provide differentiated HIV resistant mature immune cells including T lymphocytes, Macrophages, and Dendritic cells.